Shares of RXO Inc (Symbol: RXO) have surpassed the average analyst 12-month target price of $20.30, currently trading at $20.90 per share. This milestone indicates potential shifts in analyst sentiments, as they may either downgrade their valuation or revise the target price upward. The average target is derived from 15 analysts, with ranges varying from a low of $13.00 to a high of $25.00, reflecting a standard deviation of $3.239.
The latest breakdown of analyst ratings for RXO reveals 4 Strong Buy ratings, 9 Hold ratings, and 3 Strong Sell ratings, with an average rating of 2.88 on a scale where 1 is Strong Buy and 5 is Strong Sell. The data indicates a cautious optimism within the analyst community, as investors must now assess whether RXO’s price is approaching a peak or if further gains are anticipated.
